07:00 , Aug 19, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Non-small cell lung cancer (NSCLC) BRF2, subunit of RNA polymerase III transcription initiation factor, BRF1-like (BRF2) A study in cell culture and in patient...